Sleep apnea refers to a condition in which breathing gets interrupted during sleep. If left untreated, it could result in the development of various issues like high blood pressure , stroke , heart failure, irregular heartbeats, heart attacks, diabetes, depression, worsening of ADHD and headaches. The people with excessive weight, large neck size, large tonsils, a large tongue, or a small jaw bone, family history of sleep apnea, gastro esophageal reflux, or GERD, nasal obstruction due to a deviated septum, allergies, or sinus problems are generally susceptible to develop sleep apnea. It is also reported that gender and age influence sleep apnea condition. It is found more in male patients and in people over the age of 40. There are generally two types of sleep apnea. The common type is the Obstructive sleep apnea (OSA) that occurs due to the blockage of airway, when soft tissue at the back of throat collapses. The other type is caused due to the inability of brain, to provide appropriate signals to the muscles for relaxed breathing. This is mainly due to the instability of respiratory centre; and the condition is known as central sleep apnea. Sleep apnea could reduce the level of concentration in adults and children due to inadequate oxygen supply during sleep. As a result, this could cause accidents.
Market value of sleep apnea diagnostic and therapeutic devices:
The key competitors in the market scene include Koike Medical, Phlips Respironics, Curative Medical, Breas, Res Med, Covidien, Nidek Medical India, Fisher & Paykel Healthcare, Somnetics International, DeVilbiss Healthcare, SLS Medical Technology, Apex, Watermark Medical, Weinmann, Compumedics Limited, Teijin Pharma, Contec Medical, BMC Medical, WideMed, and Embla Systems. The Global Market Value Of Sleep Apnea Diagnostic And Therapeutic Devices has increased manifold due to the increased awareness created amongst people regarding the ill-effects of sleep apnea. Market analysts have predicted the market status to grow at a significant Cumulative Average Growth Rate (CAGR) percent within few years as there are increased numbers of patients visiting sleep clinics to treat sleep apnea disorder. The major areas providing high revenue yield include North America, Europe, China, Japan, Southeast Asia and India.
The pivotal market driver for the advent of various diagnostic and therapeutic devices has always been the increased level of urbanization and new technological advancements. Technology has rendered people with ample comfort opportunities and has effectively reduced their rates of physical activity.
Sleep apnea could turn out detrimental if left careless and hence, appropriate measures are to be taken for effective treatment. The market has great potential to grow in the impending years.